Mehar Chand Sharma Selected Research

Methyltransferases

4/2016	Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas.
8/2014	Meningeal hemangiopericytomas: a clinicopathological study with emphasis on MGMT (O(6) -methylguanine-DNA methyltransferase) promoter methylation status.
10/2012	A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma.
3/2011	O6 -methylguanine DNA methyltransferase gene promoter methylation in high-grade gliomas: a review of current status.
12/2010	O6-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mehar Chand Sharma Research Topics

Disease

42	Neoplasms (Cancer) 04/2024 - 08/2002
12	Glioma (Gliomas) 12/2023 - 09/2009
9	Ependymoma 02/2024 - 05/2018
9	Glioblastoma (Glioblastoma Multiforme) 07/2021 - 06/2004
6	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 04/2011
4	Oligodendroglioma 08/2018 - 06/2004
4	Multiple Myeloma 05/2016 - 04/2012
3	Temporal Lobe Epilepsy 04/2024 - 10/2021
3	Lymphoma (Lymphomas) 07/2023 - 08/2018
3	Neoplasm Metastasis (Metastasis) 01/2023 - 07/2016
3	Drug Resistant Epilepsy 07/2022 - 06/2006
3	Hypoxia (Hypoxemia) 02/2022 - 04/2013
3	Necrosis 03/2016 - 04/2011
3	Medulloblastoma 11/2005 - 08/2002
3	Astrocytoma (Pilocytic Astrocytoma) 06/2005 - 01/2004
2	Seizures (Absence Seizure) 04/2024 - 06/2023
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2024 - 08/2016
2	Rhabdomyosarcoma 11/2023 - 05/2007
2	Ewing Sarcoma (Sarcoma, Ewing) 04/2023 - 04/2015
2	Hippocampal Sclerosis 07/2022 - 10/2021
2	Inflammation (Inflammations) 07/2022 - 10/2018
2	Adenoid Cystic Carcinoma (Cylindroma) 02/2022 - 12/2021
2	Primitive Neuroectodermal Tumors (PNET) 07/2021 - 01/2021
2	Hyperplasia 08/2016 - 05/2011
2	Meningioma (Meningiomas) 07/2016 - 07/2014
2	Carcinoma (Carcinomatosis) 10/2015 - 10/2011
2	Squamous Cell Carcinoma of Head and Neck 01/2012 - 05/2011
1	Nelson Syndrome 05/2024
1	Epilepsy (Aura) 04/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2024
1	Neuroinflammatory Diseases 04/2024
1	Nervous System Diseases (Neurological Disorders) 04/2024
1	Alveolar Soft Part Sarcoma 01/2024
1	Cushing Syndrome 12/2023
1	Hypokalemia 12/2023
1	Thyroid Neoplasms (Thyroid Cancer) 09/2022
1	Thalassemia 01/2022
1	Intellectual Disability (Idiocy) 01/2022
1	Disease Progression 11/2021

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2002
9	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2012
7	DNA (Deoxyribonucleic Acid)IBA 04/2016 - 12/2010
6	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 12/2010
5	MethyltransferasesIBA 04/2016 - 12/2010
5	ErbB Receptors (EGF Receptor)IBA 03/2014 - 06/2006
4	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 11/2015
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022 - 04/2013
4	Temozolomide (Temodar)FDA LinkGeneric 07/2021 - 12/2010
3	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2023
3	Transcription Factors (Transcription Factor)IBA 07/2020 - 10/2018
3	SynaptophysinIBA 03/2016 - 01/2004
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2023 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2018
2	3-hydroxyphenyltrimethylammoniumIBA 01/2022 - 05/2011
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2021 - 05/2018
2	Melanins (Melanin)IBA 10/2020 - 03/2016
2	Messenger RNA (mRNA)IBA 01/2017 - 07/2013
2	Histones (Histone)IBA 01/2017 - 12/2014
2	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2013 - 04/2013
2	AngiopoietinsIBA 07/2013 - 04/2013
2	Angiopoietin-2IBA 07/2013 - 04/2013
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2024
1	ProteomeIBA 04/2024
1	Beclin-1IBA 04/2024
1	N-Myc Proto-Oncogene ProteinIBA 02/2024
1	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2023
1	Amino Acids FDA Link 12/2023
1	fluorocholineIBA 12/2023
1	fluorodopa F 18IBA 12/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2023
1	Phosphotransferases (Kinase)IBA 11/2023
1	tyrosine receptor (receptor, tyrosine)IBA 11/2023
1	Reticulin (Reticular Fiber)IBA 06/2023
1	N-acetoacetyl-N-deacetylcolchicineIBA 04/2023
1	Alkaline PhosphataseIBA 01/2023
1	Carboplatin (JM8)FDA LinkGeneric 01/2023
1	Ubiquitin-Specific ProteasesIBA 01/2023
1	IceIBA 01/2023
1	Ifosfamide FDA LinkGeneric 01/2023
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	NitrogenIBA 10/2022
1	MucinsIBA 09/2022
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 09/2022
1	Activating Transcription Factor 3IBA 07/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2022
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2022
1	Notch1 ReceptorIBA 12/2021

Therapy/Procedure

12	Therapeutics 04/2024 - 08/2002
12	Drug Therapy (Chemotherapy) 04/2023 - 05/2007
10	Radiotherapy 01/2023 - 08/2003
3	Neoadjuvant Therapy 12/2022 - 04/2011
2	Adjuvant Radiotherapy 07/2021 - 10/2006
1	Reoperation 05/2024
1	Nephrectomy 01/2024
1	Splenectomy 07/2023
1	Combined Modality Therapy 01/2023
1	Craniospinal Irradiation 01/2023
1	Adjuvant Chemotherapy 12/2022